MedPath

povidoneiodine pleurodesis

Not Applicable
Conditions
pleural effusion.
Secondary malignant neoplasm of pleura
Registration Number
IRCT2015071423202N1
Lead Sponsor
Respiratory Center-University of Guilan
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
1
Inclusion Criteria

inclusion criteria: patients with malignant and massive pleural effusion
exclusion criteria:underline thyroid disease; underline renal disease; Lack of consent to participate in research

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Successful pleurodesis. Timepoint: 2 weeks- 4 weeks- 6 months after intervention. Method of measurement: chest X ray.
Secondary Outcome Measures
NameTimeMethod
BUN. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;Serum creatinin. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;TSH. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;T3. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.;T4. Timepoint: before intervention-first day after and 4 weeks later. Method of measurement: laboratory test.
© Copyright 2025. All Rights Reserved by MedPath